Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Leash Biosciences
Leash Biosciences builds a large experimental dataset and ML models to improve how small molecules are designed for specific protein targets. They generate high-throughput protein-molecule…
Leash Biosciences
Leash Biosciences builds a large experimental dataset and ML models to improve how small molecules are designed for specific protein targets. They generate high-throughput protein-molecule…
TL;DR
What they do: ML-driven platform that pairs large-scale protein–small-molecule interaction datasets with experimental workflows to design and prioritize small molecules
Stage & funding: Seed stage; reported total funding about 9.3M USD (last round 2024-04-05)
Scale claims: Reports ~30 billion measured interactions and ~6.7 million ML-designed molecules
Founders / leadership: Co-founders Ian Quigley (CEO) and Andrew Blevins (CTO)
Company Overview
Problem Domain
Early-stage small-molecule drug discovery; improving medicinal chemistry by supplying large-scale protein–ligand interaction data and ML guidance.
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
9300000
Round reported with multiple investors (seven investors listed across public profiles)
Investor Signal
“Includes investors such as SpringTide Ventures, Top Harvest Capital, Mitsui Global Investment, MFV Partners, Metaplanet, Blake Borgeson, Chris Gibson”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week